Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
A MajlisF Cabanillas

Abstract

Clinical data and histologic material were retrospectively analyzed in 46 cases of previously untreated mantle cell lymphoma (MCL) to more fully characterize the clinical response pattern of these lymphomas and to determine whether growth pattern significantly affected clinical outcome. The histologic pattern was classified as diffuse (61%), nodular (13%), and mantle zone (26%) in accordance with stated criteria. Bone marrow infiltration was detected in 69% of cases; the frequency of involvement correlated with histologic pattern, being most common in diffuse variants and least common in mantle zone variants. Other sites of extranodal involvement were observed in 50% of cases. Cyclin-D1 staining revealed nuclear positivity in 23 of 25 patients (92%) and no difference was observed between the various histologic patterns. Rearrangement at the bcl-1 major translocation cluster (MTC) was detected in seven of 21 cases, without regard for histologic pattern. Complete response rates to doxorubicin-based regimens showed a striking correlation with histologic pattern. Seventy-three percent of patients with a mantle zone pattern attained a complete response compared with only 25% of patients with a nodular pattern and 19% with a diffuse ...Continue Reading

Citations

Aug 11, 2000·Applied Immunohistochemistry & Molecular Morphology : AIMM·H W KorinM Younes
Aug 30, 2002·British Journal of Haematology·Rosa RuchlemerDaniel Catovsky
Oct 27, 2007·Expert Opinion on Biological Therapy·Samuel A Jacobs, Kenneth A Foon
Jun 10, 2008·Current Opinion in Hematology·Mitchell R Smith
Apr 16, 2008·British Journal of Haematology·Pedro Jares, Elías Campo
Feb 25, 2014·Expert Review of Hematology·Yu Wang, Shuangge Ma
Feb 3, 2015·Therapeutic Advances in Hematology·Babak Rajabi, John W Sweetenham
Dec 5, 1998·American Journal of Hematology·C S ChimR Liang
Dec 26, 2001·Current Opinion in Hematology·John L Frater, Eric D Hsi
Jun 12, 2002·Current Treatment Options in Oncology·J J Densmore, M E Williams
Aug 27, 2005·Expert Opinion on Biological Therapy·Samuel A Jacobs, Kenneth A Foon
Mar 4, 2006·British Journal of Haematology·M B MøllerB E Christensen
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lloyd E DamonGeorge P Canellos
Oct 2, 2012·The Journal of Clinical Investigation·Pedro JaresElias Campo
Mar 10, 2015·Leukemia & Lymphoma·Rajesh ShresthaJames O Armitage
Jul 17, 2019·Journal of Gastrointestinal Cancer·Atsushi GotoIsao Sakaida
Jan 22, 2002·The American Journal of Dermatopathology·B R MoodyM D Kraus
Sep 1, 2005·Virchows Archiv : an International Journal of Pathology·Carsten SchraderMarkus Tiemann
Oct 19, 2005·Virchows Archiv : an International Journal of Pathology·Marcus KremerFalko Fend
Dec 29, 2004·Leukemia & Lymphoma·Joshua RifkindJeffrey H Lipton
Jul 10, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rashmi S GoswamiSuzanne Kamel-Reid
Sep 27, 2006·The American Journal of Surgical Pathology·Antonio SalarSergio Serrano
Jun 27, 2009·Blood·Michele Ghielmini, Emanuele Zucca
May 30, 2019·American Journal of Clinical Pathology·Ji YuanZenggang Pan
Jun 22, 2000·American Journal of Hematology·D D WeisenburgerJ O Armitage
May 31, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John F SeymourPeter McLaughlin
Aug 25, 2015·Virchows Archiv : an International Journal of Pathology·Birgitta SanderElias Campo
Sep 8, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jorge E RomagueraFernando F Cabanillas
Feb 2, 2002·Human Pathology·Steven H Swerdlow, Michael E Williams

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
Dong-mei WangJian-Yong Li
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Hai-xi ZhangCai-gang Xu
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Wei-ying BaoWei-li Zhao
© 2021 Meta ULC. All rights reserved